Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-10-23

Clinical Trial Update: Ultra-Widefield Fluorescein Angiography-Based Targeted Retinal Photocoagulation Versus Conventional Panretinal Photocoagulation in the Preservation of Visual Function and Regression of Proliferative Diabetic Retinopathy [NA]

View source ↗

Summary

Completed clinical trial comparing ultra-widefield fluorescein angiography-guided targeted retinal photocoagulation versus conventional panretinal photocoagulat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Hayatabad Medical Complex | Conditions: Proliferative Diabetic Retinopathy - High Risk | NA | Status: COMPLETED